Congratulations to research fellow Dr Lisa Kouladjian O’Donnell who has received a prestigious award for her contribution to pharmacology. Lisa was presented with the ASCEPT Early Achievement Award for Women during the annual meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists. This year’s event was held in Perth in collaboration with the Au.....
Read more

A new study by researchers at the Kolling Institute, in collaboration with the Microbiome Research Centre, has shown that multiple medication use impacts gut microbiome, and may influence the ageing process. Gizem Gemikonakli, a PhD student at the University of Sydney, said their findings followed a longitudinal, in vivo study. “Interestingly, mice that were given a regimen of five thera.....
Read more

We would like to congratulate Kolling Institute researcher Professor Sarah Hilmer who has been elected a Fellow of the prestigious Australian Academy of Health and Medical Sciences. Professor Hilmer is part of a select group of researchers who have been admitted to the academy, which works to advance health and medical research across Australia. She has joined the highly-respected organi.....
Read more

An impressive group of emerging leaders addressed the Kolling’s Neuroscience and Pain Showcase, sharing details of their diverse and exciting research projects. With a broad range of expertise in this field, the showcase involved representatives from the pain management and rehabilitations teams, as well as the ageing, mental health, neurogenetics and neuromuscular imaging groups. The ea.....
Read more

We would like to congratulate our Kolling Institute researcher Professor Sarah Hilmer who’s been awarded an AM for her service to clinical and geriatric pharmacology as part of the Queen’s birthday honours. Professor Hilmer has worked as the Head of Clinical Pharmacology and as a geriatrician at Royal North Shore Hospital since 2005. Her research and clinical expertise is respected both .....
Read more

A new study by researchers at the Kolling Institute will directly guide the use of medications by older Australians after it identified the profound adverse effects of taking multiple medications. The study follows the latest figures which show around 50 per cent of Australians over 75 years take five or more medications every day to treat multiple chronic illnesses. The trend is leading.....
Read more

Acting Executive Director Professor Jim Elliott has announced the winners of the inaugural Kolling Institute Emerging Leader Awards, saying there’s an inspiring depth of expertise throughout the institute. Professor Elliott said the new awards recognise our young leaders across our basic and translational research, and were initiated by the institute’s Workforce and Culture Enabler Commi.....
Read more

A team from the Kolling Institute led by Professor Sarah Hilmer has helped develop a valuable, new national program to reduce the adverse impacts of taking multiple medicines. Medicines with an anticholinergic effect can successfully treat many conditions such as depression, dementia and chronic non-cancer pain. Cumulatively however, they can cause serious adverse effects such as falls, .....
Read more

Researchers from the Kolling Institute will support an important, Australia-wide project to address the inappropriate use of medications in residential aged care. The initiative, to be co-ordinated by Monash University’s Centre for Medicine Use and Safety, has been awarded $2 million through the Medical Research Future Fund. It will see pharmacists embedded in residential aged care.....
Read more

Two Royal North Shore Hospital clinician researchers will play a key role in a national research project to improve the use of medications across the community. Head of the Department of Clinical Pharmacology and Kolling researcher Professor Sarah Hilmer and Head of the Department of General Practice Associate Professor Fiona Robinson will help drive the project which has been awarded mo.....
Read more